View : 217 Download: 0
Ccrn4l as a pre-dose marker for prediction of cisplatin-induced hepatotoxicity susceptibility
- Ccrn4l as a pre-dose marker for prediction of cisplatin-induced hepatotoxicity susceptibility
- Hwang, Da-Bin; Won, Dong-Hoon; Shin, Yoo-Sub; Kim, Shin-Young; Kang, Byeong-Cheol; Lim, Kyung-Min; Che, Jeong-Hwan; Nam, Ki Taek; Yun, Jun-Won
- Ewha Authors
- SCOPUS Author ID
- Issue Date
- Journal Title
- FREE RADICAL BIOLOGY AND MEDICINE
- FREE RADICAL BIOLOGY AND MEDICINE vol. 148, pp. 128 - 139
- Hepatotoxicity; Cisplatin; Individual variation; Susceptibility; Pre-biopsy method
- ELSEVIER SCIENCE INC
- SCIE; SCOPUS
- Document Type
- Clinical cisplatin use is often limited by its drug-induced liver injury (DILI). Particularly, individual differences in susceptibility to DILI can cause life-threatening medical conditions. This study aimed to uncover the inherent genetic factors determining individual variations in hepatotoxicity susceptibility. Rats were subjected to liver biopsy and a 3-week postoperative recovery period before cisplatin administration. At 2 days post-treatment with cisplatin, the rats exhibited histopathological and serum biochemical alterations in the liver, and changes in hydrogen peroxide and cytochrome P450-2E1 levels. Based on these results of liver-related biochemical markers, 32 rats were grouped into the susceptible (top five) and resistant (bottom five) groups. Using RNA-sequencing, we compared gene expressions in the liver pre-biopsied from these two groups before cisplatin treatment and found 161 differently expressed genes between the Susceptible and Resistant groups. Among them, the clock-controlled Ccrn4l responsible for 'rhythmic process' was identified as a common gene downregulated inherently prior to drug exposure in both cisplatin- and acetaminophen-sensitive animals. Additionally, low Ccrn4l levels before cisplatin treatment in the Susceptible group were maintained even after treatment, with decreased antioxidants, increased nitration, and apoptosis. The relationship of Ccrn4l with catalase and mitochondrial RNAs in the liver was confirmed by correlation of their hepatic levels among individuals and similar patterns of circadian variation in their mRNA expression. Remarkably, Ccrn4l knockdown promoted cisplatin-induced mitochondrial dysfunction in WB-F344 cells with antioxidant catalase and apoptosis-related Bax changes. Inherent individual hepatic Ccrn4l level might be a novel factor affecting cisplatin-induced hepatotoxicity susceptibility, possibly through regulation of mitochondrial and antioxidant functions.
- Appears in Collections:
- 약학대학 > 약학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.